Ignite Creation Date:
2025-12-25 @ 3:13 AM
Ignite Modification Date:
2026-01-08 @ 8:34 PM
Study NCT ID:
NCT07006805
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-10-31
First Post:
2025-04-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
RESET-MS: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Multiple Sclerosis
Sponsor:
Cabaletta Bio
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Relapsing Multiple Sclerosis (RMS) | View |
| None | Progressive Multiple Sclerosis (PMS) | View |
| None | Multiple Sclerosis - Relapsing Remitting | View |
| None | Multiple Sclerosis | View |
| None | Multiple Sclerosis (Relapsing Remitting) | View |
| None | Multiple Sclerosis (MS) - Relapsing-remitting | View |
| None | Progressive Multiple Sclerosis | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | CABA-201 | View |
| None | Rese-cel | View |
| None | autoimmune disease | View |
| None | anti-CD19 CAR-T therapy | View |
| None | cellular therapy | View |
| None | Multiple Sclerosis | View |
| None | Relapsing MS | View |
| None | RRMS | View |
| None | Progressive MS | View |
| None | PPMS | View |
| None | SPMS | View |
| None | Neurology | View |
| None | Resecabtagene autoleucel | View |